HSCS · NASDAQ
HeartSciences (HSCS) Stock Price & Fundamentals
HeartSciences (HSCS) closed at $448.11 on Oct 9, 2026, down 1.68% from the previous close of $455.77.
Share price, past year
1Y +3.63%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $448.11 |
| Sep 30, 2026 | $441.91 |
| Aug 31, 2026 | $424.28 |
| Jul 31, 2026 | $434.32 |
| Jun 30, 2026 | $427.62 |
| May 29, 2026 | $424.71 |
| Apr 30, 2026 | $407.86 |
| Mar 31, 2026 | $405.86 |
| Feb 27, 2026 | $412.21 |
| Jan 30, 2026 | $426.32 |
| Dec 31, 2025 | $430.10 |
| Nov 28, 2025 | $436.40 |
| Oct 31, 2025 | $448.41 |
Key statistics
- Market cap
- $1.43B
- P/E (TTM)
- —
- EPS (TTM)
- −$6.86
- Revenue (TTM)
- $4.52K
- Net income (TTM)
- −$10.26M
- Shares outstanding
- 3.2M
- Dividend yield
- —
- 52-week range
- $390.41 – $455.77
HeartSciences's market cap is $1.43B, based on a share price of $448.11 and 3.2M shares outstanding as of Jun 30, 2026.
Financials
HeartSciences reported revenue of $4.32K for fiscal 2026, down 0.71% from fiscal 2025.
HeartSciences reported a net loss of $9.14M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2026ended Apr 30, 2026 | $4.32K | −0.7% | −$9.14M | −211,666.5% | — | −$7.43M |
| FY2025ended Apr 30, 2025 | $4.35K | −76.6% | −$8.77M | −201,499.5% | −$9.34 | −$7.42M |
| FY2024ended Apr 30, 2024 | $18.60K | +261.2% | −$6.61M | −35,511.9% | −$18.74 | −$6.13M |
| FY2023ended Apr 30, 2023 | $5.15K | −64.2% | −$6.35M | −123,384.3% | −$80.00 | −$5.79M |
| FY2022ended Apr 30, 2022 | $14.37K | — | −$4.83M | −33,592.6% | −$145.00 | −$3.65M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2027ended Jul 31, 2026 | $2.10K | −$3.17M | — |
| Q4 FY2026ended Apr 30, 2026 | $0.00 | −$2.75M | — |
| Q3 FY2026ended Jan 31, 2026 | $0.00 | −$1.99M | — |
| Q2 FY2026ended Oct 31, 2025 | $2.42K | −$2.35M | −$0.85 |
| Q1 FY2026ended Jul 31, 2025 | $1.90K | −$2.05M | −$1.58 |
| Q3 FY2025ended Jan 31, 2025 | $0.00 | −$2.54M | −$2.57 |
| Q3 FY2024ended Jan 31, 2024 | $14.70K | — | −$3.01 |
| Q2 FY2024ended Oct 31, 2023 | $3.90K | — | — |
Company profile
- Name
- HeartSciences Inc.
- Ticker
- HSCS
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Finance Services
- Headquarters
- 550 Reserve St, Suite 360, Southlake, TX 76092
- Incorporated in
- TX
- Fiscal year ends
- April
- SEC CIK
- 0001468492
Recent SEC filings
- Oct 6, 2026
- Oct 2, 2026
- Sep 17, 2026
- Sep 15, 2026
- Sep 14, 2026
- Aug 20, 2026
- Aug 19, 2026
- Aug 18, 2026
Frequently asked questions
What is HeartSciences's stock price?
HeartSciences (HSCS) closed at $448.11 on Oct 9, 2026, down 1.68% from the previous close of $455.77.
What is HeartSciences's market cap?
HeartSciences's market cap is $1.43B, based on a share price of $448.11 and 3.2M shares outstanding as of Jun 30, 2026.
How much revenue does HeartSciences make?
HeartSciences reported revenue of $4.32K for fiscal 2026, down 0.71% from fiscal 2025.
Does HeartSciences pay a dividend?
Yes. HeartSciences declared $0.00 per share in dividends for fiscal 2026.
Sources and methodology
Fundamentals come from HeartSciences Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures